Reinhart Partners LLC. Sells 90,568 Shares of Encompass Health Corporation $EHC

Reinhart Partners LLC. reduced its position in Encompass Health Corporation (NYSE:EHC) by 20.0% in the 3rd quarter, HoldingsChannel reports. The firm owned 362,551 shares of the company’s stock after selling 90,568 shares during the period. Reinhart Partners LLC.’s holdings in Encompass Health were worth $46,053,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the business. Norges Bank bought a new position in Encompass Health during the second quarter worth about $139,536,000. Congress Asset Management Co. acquired a new position in shares of Encompass Health during the 2nd quarter worth approximately $92,691,000. 8 Knots Management LLC bought a new position in shares of Encompass Health during the second quarter worth approximately $78,644,000. Marshall Wace LLP acquired a new stake in shares of Encompass Health in the second quarter valued at approximately $34,719,000. Finally, Raymond James Financial Inc. boosted its stake in shares of Encompass Health by 31.5% in the second quarter. Raymond James Financial Inc. now owns 1,143,642 shares of the company’s stock valued at $140,245,000 after buying an additional 274,142 shares during the period. Institutional investors and hedge funds own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have commented on EHC shares. Zacks Research lowered Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Weiss Ratings restated a “buy (b+)” rating on shares of Encompass Health in a research report on Wednesday, October 8th. Wall Street Zen downgraded Encompass Health from a “buy” rating to a “hold” rating in a research note on Saturday, January 10th. UBS Group increased their price objective on shares of Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research note on Thursday, October 2nd. Finally, Raymond James Financial upgraded shares of Encompass Health to a “strong-buy” rating in a research report on Friday, October 31st. Two investment analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $142.86.

Encompass Health Stock Down 2.2%

Shares of NYSE EHC opened at $100.49 on Friday. The company has a market cap of $10.11 billion, a price-to-earnings ratio of 19.00, a PEG ratio of 1.65 and a beta of 0.74. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a 12 month low of $92.53 and a 12 month high of $127.99. The stock has a 50-day moving average price of $109.34 and a two-hundred day moving average price of $116.31.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Wednesday, October 29th. The company reported $1.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.19 by $0.04. Encompass Health had a net margin of 9.33% and a return on equity of 17.84%. The business had revenue of $1.48 billion during the quarter, compared to analysts’ expectations of $1.48 billion. During the same period in the prior year, the company earned $1.03 EPS. The firm’s quarterly revenue was up 9.4% compared to the same quarter last year. As a group, analysts forecast that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, January 15th. Investors of record on Friday, January 2nd were given a dividend of $0.19 per share. The ex-dividend date was Friday, January 2nd. This represents a $0.76 dividend on an annualized basis and a yield of 0.8%. Encompass Health’s payout ratio is currently 14.37%.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.